CIR (CIR) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
31 Jul, 2026Executive summary
Consolidated revenues increased by 1.7% year-over-year in H1 2026 to €913.5 million, driven by 4.3% growth at KOS and stable Sogefi performance.
Net result rose to €18.6 million from €14.5 million, mainly due to full consolidation of KOS and improved operating performance.
Major strategic moves included the acquisition of the remaining 40% of KOS, making it wholly owned, and a share buyback program.
Sogefi agreed to sell its precision springs business for €21 million.
Operating performance improved, supported by higher financial portfolio income.
Financial highlights
Group revenues reached €913.5 million in H1 2026, up from €898.4 million in H1 2025.
EBITDA increased to €142.1 million (15.6% margin), and EBIT to €57.5 million (6.3% margin).
Net financial position shifted from +€220.4 million at Dec 2025 to -€24.7 million at June 2026, mainly due to the KOS acquisition and share buybacks.
KOS net debt increased by €56 million, mainly from dividend payments and capex; Sogefi net debt decreased by €10.9 million.
Parent company net financial position decreased from €362.3 million to €162.3 million, reflecting KOS acquisition and buybacks.
Outlook and guidance
KOS expects to consolidate gains with slightly higher results than last year; full effect of Italian rehab tariff increases expected from 2027.
Sogefi anticipates a low single-digit revenue decline for the full year, with EBIT margin guidance confirmed at 25% and stable adjusted EBIT margin.
Persistent macroeconomic and geopolitical uncertainties expected to drive market volatility.
Occupancy rates in Italy near capacity; Germany has upside potential as some regions lag.
Group net income for 2026 is expected to exceed 2025 levels barring extraordinary events.
Latest events from CIR
- Operating margins improved, but net income fell as one-off gains were not repeated.CIR
H1 20252 Jun 2026 - Net profit soared to €114.3M in H1 2024, driven by asset sales and strong healthcare growth.CIR
H1 20242 Jun 2026 - EBITDA and EBIT margins improved as KOS grew and Sogefi faced headwinds.CIR
H2 202513 Mar 2026 - Net income surged to €132.2M on asset sales and margin gains; share buybacks boosted equity.CIR
H2 202426 Dec 2025